Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $7.06 Analyst target: $29.40 Upside: 316.43%
Precision BioSciences, Inc., a genome editing company, develops therapeutic products in the United States. The company is headquartered in Durham, North Carolina.
See the full interactive analysis & chart →Informational only — not investment advice.